Paul Tudor Jones’s Zimmer Biomet ZBH Stock Holding History

Paul Tudor Jones’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$499K	Buy	+5,800	New	+$509K	﹤0.01%	2826
2026 Q1	–	Sell	-5,100	Closed	-$459K	–	4386
2025 Q4	$459K	Sell	5,100 -1,600	-24%	-$152K	﹤0.01%	2766
2025 Q3	$660K	Sell	6,700 -1,500	-18%	-$149K	﹤0.01%	2536
2025 Q2	$748K	Buy	8,200 +1,800	+28%	+$174K	﹤0.01%	2324
2025 Q1	$724K	Buy	+6,400	New	+$685K	﹤0.01%	2038
2023 Q4	–	Sell	-4,400	Closed	-$494K	–	2976
2023 Q3	$494K	Sell	4,400 -100	-2%	-$12.7K	0.01%	1685
2023 Q2	$655K	Sell	4,500 -200	-4%	-$27.2K	0.01%	1564
2023 Q1	$607K	Buy	+4,700	New	+$590K	0.01%	1512
2022 Q1	–	Sell	-2,163	Closed	-$269K	–	2788
2021 Q4	$269K	Sell	2,163 -412	-16%	-$53.9K	﹤0.01%	1918
2021 Q3	$367K	Buy	+2,575	New	+$379K	0.01%	1880

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Paul Tudor Jones's ZBH Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 71,996 shares worth $6.2M. The stake represents 0.01% of the portfolio and ranks #1136 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in ZBH as recently as Q4 2025.

Paul Tudor Jones first reported a position in ZBH in Q2 2013 and has held it in 37 quarters since. The position peaked at $55.1M in Q3 2016. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Paul Tudor Jones held 71,996 shares of Zimmer Biomet worth $6.2M as of Q2 2026.
Zimmer Biomet was a new Paul Tudor Jones position in Q2 2026.
Zimmer Biomet made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1136 holding.
Paul Tudor Jones first reported a position in Zimmer Biomet in Q2 2013 and has held it in 37 quarters since.
Paul Tudor Jones's Zimmer Biomet position peaked at $55.1M in Q3 2016.
904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.